Cellectis (CLLS) Non-Current Assets (2014 - 2026)

Cellectis (CLLS) recorded quarterly Non-Current Assets of $84.6 million in Q1 2026, down 4.34% quarter-over-quarter from $88.5 million in Q4 2025, and down 8.26% on a YoY basis from $92.3 million in Q1 2025.

Cellectis (CLLS) Non-Current Assets (2014 - 2026) Analysis & Trends

Cellectis' Non-Current Assets history runs 13 years deep, the most recent figure standing at $84.6 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 8.26% year-over-year to $84.6 million; the TTM figure through Mar 2026 stood at $84.6 million (down 8.26% YoY), while the FY2025 annual figure was $88.5 million, down 8.29% from the prior year.
  • Non-Current Assets was $84.6 million for Q1 2026 at Cellectis, down from $88.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $152.0 million in Q1 2022 to a low of $84.6 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $112.0 million across 5 years, with a median of $113.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets fell 25.05% in 2022, then grew 21.69% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $117.4 million in 2022, then slipped by 13.75% to $101.3 million in 2023, then retreated by 4.73% to $96.5 million in 2024, then declined by 8.29% to $88.5 million in 2025, then declined by 4.34% to $84.6 million in 2026.
  • The last three Non-Current Assets figures came in at $84.6 million (Q1 2026), $88.5 million (Q4 2025), and $121.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Cellectis 17.40 Bn 17.21 Bn - 84.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.64 Mn
Dec 31, 2025 88.48 Mn
Sep 30, 2025 121.85 Mn
Jun 30, 2025 123.33 Mn
Mar 31, 2025 92.26 Mn
Dec 31, 2024 96.48 Mn
Sep 30, 2024 101.45 Mn
Jun 30, 2024 101.34 Mn
Mar 31, 2024 96.39 Mn
Dec 31, 2023 101.27 Mn
Sep 30, 2023 113.21 Mn
Jun 30, 2023 114.39 Mn
Mar 31, 2023 114.04 Mn
Dec 31, 2022 117.41 Mn
Sep 30, 2022 139.31 Mn
Jun 30, 2022 145.72 Mn
Mar 31, 2022 152.02 Mn
Dec 31, 2021 156.65 Mn
Sep 30, 2021 177.04 Mn
Jun 30, 2021 177.21 Mn